4 results on '"Weidman D"'
Search Results
2. Computed Tomography Findings in Vernix Caseosa Peritonitis.
- Author
-
Becker-Weidman D, Chung CMC, Nadeem M, Virk J, and Chung C
- Subjects
- Abdomen diagnostic imaging, Adolescent, Adult, Cesarean Section adverse effects, Cysts diagnostic imaging, Cysts pathology, Cysts surgery, Female, Foreign-Body Reaction pathology, Foreign-Body Reaction surgery, Humans, Laparoscopy, Peritonitis pathology, Peritonitis surgery, Pregnancy, Pregnancy Complications pathology, Pregnancy Complications surgery, Tomography, X-Ray Computed, Young Adult, Foreign-Body Reaction diagnostic imaging, Peritonitis diagnostic imaging, Pregnancy Complications diagnostic imaging, Vernix Caseosa cytology, Vernix Caseosa immunology
- Abstract
Introduction: Vernix caseosa peritonitis (VCP) is a rare peripartum complication secondary to the introduction of fetal vernix into the maternal peritoneal cavity. Vernix caseosa peritonitis typically manifests a few hours to days after a cesarian section and is often initially misdiagnosed as a more common disease process resulting in delayed diagnosis. We report the computed tomography (CT) findings in 2 patients with VCP and reviewed the previously reported CT findings of VCP., Cases: Two patients, aged 17 and 24 years, presented with signs and symptoms of peritonitis within days of undergoing a cesarian section. In both cases, CT scans of the abdomen and pelvis demonstrated ascites and multiple small, well-defined, peripherally enhancing, cystic peritoneal nodules which were most prominent around the liver and became larger and more numerous over time. Antibiotic therapy was not effective, subsequent laparoscopic peritoneal biopsy demonstrated VCP, and patients were successfully treated with lavage and the addition of intravenous steroids., Conclusions: Vernix caseosa peritonitis is an underrecognized disorder that is most often mistaken for other more common causes of peritonitis. In the setting of peripartum peritonitis, the CT findings of ascites with multiple small, well-defined, peripherally enhancing, cystic peritoneal nodules, especially adjacent to the liver, which grow in size and number strongly suggests VCP.
- Published
- 2020
- Full Text
- View/download PDF
3. Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.
- Author
-
Duan L, Renzi S, Weidman D, Waespe N, Chami R, Manson D, Cada M, and Carcao M
- Subjects
- Hemangioendothelioma diagnosis, Humans, Infant, Newborn, Kasabach-Merritt Syndrome diagnosis, Male, Pericardial Effusion diagnosis, Pleural Effusion, Malignant diagnosis, Sarcoma, Kaposi diagnosis, Hemangioendothelioma drug therapy, Kasabach-Merritt Syndrome drug therapy, Pericardial Effusion drug therapy, Pleural Effusion, Malignant drug therapy, Sarcoma, Kaposi drug therapy, Sirolimus administration & dosage
- Abstract
Kaposiform hemangioendothelioma (KHE) is a rare infiltrative vascular tumor that may be associated with Kasabach-Merritt Phenomenon (KMP), which is a consumptive coagulopathy with potentially life-threatening thrombocytopenia. Management of KHE and KMP is challenging, and currently, there are no standardized validated treatment protocols. Mammalian target of rapamycin inhibitors have been shown to be effective in the treatment of KHE. We describe a term male who presented as a diagnostic dilemma with life-threatening pleural and pericardial effusions and severe thrombocytopenia. After extensive work-up the etiology for his condition was determined to be KHE with KMP. The patient was commenced on sirolimus and responded well to therapy with resolution of KMP.
- Published
- 2020
- Full Text
- View/download PDF
4. The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes.
- Author
-
Yurkova N, Shaw J, Blackie K, Weidman D, Jayas R, Flynn B, and Kirshenbaum LA
- Subjects
- Animals, Cell Cycle physiology, Cells, Cultured, E2F1 Transcription Factor genetics, Gene Expression Regulation physiology, Hypoxia metabolism, Hypoxia physiopathology, Mitochondria physiology, Mitochondrial Proteins, Myocytes, Cardiac physiology, Rats, Rats, Sprague-Dawley, Signal Transduction physiology, Transcriptional Activation physiology, Transfection, Apoptosis physiology, E2F1 Transcription Factor metabolism, Membrane Proteins genetics, Membrane Proteins metabolism, Myocytes, Cardiac cytology, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism
- Abstract
The cell cycle factor E2F-1 is known to regulate a variety of cellular processes including apoptosis. Previously we showed that disruption of Rb-E2F-1 complexes provoked apoptosis of postmitotic adult and neonatal ventricular myocytes; however, the underlying mechanism was undetermined. In this report, we show that E2F-1 provokes cell death of ventricular myocytes through a mechanism that directly impinges on the intrinsic death pathway. Furthermore, we show mechanistically that the hypoxia-inducible death factor Bnip3 is a direct transcriptional target of E2F-1 that is necessary and sufficient for E2F-1-induced cell death. Expression of E2F-1 resulted in a 4.9-fold increase (P<0.001) in nucleosomal DNA fragmentation and cell death by Hoechst 33258 dye and vital staining. E2F-1 provoked mitochondrial perturbations that were consistent with permeability transition pore opening. As determined by quantitative real-time PCR analysis, a 6.2-fold increase (P<0.001) in endogenous Bnip3 gene transcription was observed in cells expressing wild-type E2F-1 but not in cells expressing a mutation of E2F-1 defective for DNA binding. Rb, the principle regulator of cellular E2F-1 activity, was proteolytically cleaved and inactivated in ventricular myocytes during hypoxia. Consistent with the proteolytic cleavage of Rb, chromatin immunoprecipitation analysis revealed increased binding of E2F-1 to the Bnip3 promoter during hypoxia, a finding concordant with the induction of Bnip3 gene transcription. The Bnip3 homolog Nix/Bnip3L was unaffected in ventricular myocytes by either E2F-1 or hypoxia. Genetic knockdown of E2F-1 or expression of a caspase-resistant form of Rb suppressed basal and hypoxia-inducible Bnip3 gene transcription. Loss-of-function mutations of Bnip3 defective for mitochondrial membrane insertion or small interference RNA directed against Bnip3 suppressed cell death signals elicited by E2F-1. To our knowledge, the data provide the first direct evidence that activation of the intrinsic mitochondrial death pathway by E2F-1 is mutually dependent on and obligatorily linked to the transcriptional activation of Bnip3.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.